Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
2
users have commented on this narrative
18
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Metro Bank Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Upgrades And Asset Rotation Will Drive Banking Evolution
Key Takeaways Relationship-led banking and digital upgrades increase customer stickiness, efficiency, and margin growth while supporting personalized service differentiation. Strategic shift to higher-yield lending and regional expansion strengthen growth prospects, balance sheet resilience, and long-term capacity for capital returns.
View narrative
UK£1.42
FV
10.8% undervalued
intrinsic discount
22.80%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
5 days ago
author updated this narrative
MyState
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Auswide Bank Merger And Digital Banking Will Increase Operational Efficiency
Key Takeaways Merger with Auswide Bank expands MyState's scale and reach, enabling growth and efficiency improvements. Technology investments and enhanced customer services could reduce costs and boost net margins and profitability.
View narrative
AU$4.84
FV
5.8% undervalued
intrinsic discount
22.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
ImmunoPrecise Antibodies
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
AI-Driven Discovery Will Advance Biologic Drug Development
Key Takeaways Accelerated adoption of AI-driven platforms and regulatory changes are boosting demand for ImmunoPrecise's scalable, high-margin discovery and screening services. Strategic partnerships, operational efficiencies, and core market expansion are supporting recurring revenue growth, improved margins, and stronger long-term earnings stability.
View narrative
US$4.00
FV
35.8% undervalued
intrinsic discount
21.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
5 days ago
author updated this narrative
KMD Brands
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Digital Platforms And New Stores Will Improve Retail Efficiency
Key Takeaways Investments in digital platforms, eCommerce and strategic marketing are expected to enhance online sales, brand recognition, and revenue growth. Store expansions and operational upgrades aim to boost direct-to-consumer sales and improve operational efficiency, supporting higher earnings and net margins.
View narrative
NZ$0.36
FV
30.6% undervalued
intrinsic discount
4.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
5 days ago
author updated this narrative
Indegene
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Digital Transformation And AI Adoption Will Expand Pharma Market
Key Takeaways AI-driven digital solutions and deeper multi-year client relationships are expanding Indegene's market presence, improving revenue growth and operational efficiencies in pharma services. Strategic reinvestment and targeted acquisitions are shifting revenues toward higher-margin, technology-led offerings and expanding capabilities across new verticals and geographies.
View narrative
₹644.67
FV
8.5% undervalued
intrinsic discount
12.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Remitly Global
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Wallets And Stablecoins Will Expand Remittance Markets
Key Takeaways Expansion into digital memberships, wallets, and stablecoins boosts global reach, revenue diversity, and customer loyalty amid rising cross-border and digital financial activity. AI integration and industry trends toward formalization and regulation lower costs, improve margins, and accelerate Remitly's shift from cash to digital leadership.
View narrative
US$28.60
FV
34.1% undervalued
intrinsic discount
20.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
5 days ago
author updated this narrative
Biofrontera
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Label Expansion And New Trials Will Fuel US Dermatology Demand
Key Takeaways Expansion of Ameluz indications, improved reimbursement, and patent extension are set to drive revenue growth and strengthen market position amid rising skin cancer rates. Reduced costs due to lower royalties and focus on new dermatological indications are expected to improve margins and enable future product launches.
View narrative
US$6.38
FV
85.4% undervalued
intrinsic discount
21.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 days ago
author updated this narrative
Verbio
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Global Decarbonization Targets And US Production Will Create Market Tailwinds
Key Takeaways Tightening biofuel supply, favorable policy shifts, and global decarbonization targets are driving demand and price improvements, supporting Verbio’s revenue growth and pricing power. Strategic cost control, technology-driven efficiency gains, and expansion into specialty chemicals and high-value renewables are set to materially lift margins and strengthen the balance sheet.
View narrative
€14.52
FV
29.4% undervalued
intrinsic discount
13.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
5 days ago
author updated this narrative
Harrow
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Rising Specialty Ophthalmics And Biosimilars Will Open New Markets
Key Takeaways Accelerating demand for Harrow's specialty eye drugs and expansion into new treatment areas support strong, sustained top-line and margin growth. Improved patient access, partnerships, and integration of new innovative products strengthen competitive positioning and enable outsized earnings growth.
View narrative
US$59.78
FV
36.0% undervalued
intrinsic discount
38.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies